Hepatic extramedullary disease in multiple myeloma with 17p deletion. [electronic resource]
Producer: 20150525Description: e165-8 p. digitalISSN:- 2152-2669
- Aneuploidy
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Boronic Acids -- administration & dosage
- Bortezomib
- Chromosome Aberrations
- Chromosome Deletion
- Chromosomes, Human, Pair 17 -- ultrastructure
- Clone Cells -- chemistry
- Dexamethasone -- administration & dosage
- Fatal Outcome
- Female
- Gene Deletion
- Genes, p53
- Humans
- Incidental Findings
- Lenalidomide
- Liver -- pathology
- Middle Aged
- Multiple Myeloma -- chemistry
- Neoplasm Proteins -- analysis
- Neoplasms, Multiple Primary
- Osteolysis -- diagnosis
- Proteasome Inhibitors -- administration & dosage
- Pyrazines -- administration & dosage
- Recurrence
- Thalidomide -- administration & dosage
- Tumor Suppressor Protein p53 -- analysis
- Uterine Neoplasms -- surgery
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.